3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
9
Leukemia
8
Leukemia, Myeloid, Chronic-Phase
7
Burkitt Lymphoma
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Prostatic Neoplasms
3
Multiple Myeloma
3
Lymphoma
3
Philadelphia Chromosome
2
Pancreatic Neoplasms
2
Neoplasms
2
Leukemia, Myeloid, Acute
2
Leukemia, Biphenotypic, Acute
2
Hematologic Neoplasms
2
Glioma
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Recurrence
1
Rectal Neoplasms
1
Prostate Cancer Recurrent
1
Primary Myelofibrosis
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Ovarian Neoplasms
1
Neuroblastoma
1
Neoplasm, Residual
1
Interventions
Rituximab
53
Cyclophosphamide
50
Lenalidomide
41
fludarabine
24
obinutuzumab
23
Prednisone
19
Bendamustine Hydrochloride
19
Magnetic Resonance Spectroscopy
18
Vincristine
17
Doxorubicin
16
fludarabine phosphate
15
Specimen Handling
15
zanubrutinib
13
Biopsy
12
tazemetostat
10
ibrutinib
10
Whole-Body Irradiation
10
pembrolizumab
9
Peripheral Blood Stem Cell Transplantation
9
venetoclax
8
Mycophenolic Acid
7
Etoposide
7
axicabtagene ciloleucel
6
Radiotherapy
6
CT-P10
6
Therapeutics
5
R-CHOP protocol
5
tafasitamab
4
polatuzumab vedotin
4
acalabrutinib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Follicular
×
Dasatinib
×
1 year
×
Clear all
No trials found.